2019 Senate Bill 5391: Requiring the disclosure of drug production in improved residential real property sales

Introduced by Sen. Hans Zeiger (Puyallup) (R) on January 18, 2019

Referred to the Senate Financial Institutions, Economic Development & Trade Committee on January 18, 2019

Substitute offered in the Senate on February 14, 2019

Requires a seller of residential real estate to disclose in writing whether the improved residential property was ever used to manufacture drugs.

Referred to the Senate Rules Committee on February 15, 2019